| Maureen Ann Mcdonald, MD | |
|
9855 Hospital Dr Ste 275, Maple Grove, MN 55369-4778 | |
| (952) 993-3282 | |
| Not Available |
| Full Name | Maureen Ann Mcdonald |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 9 Years |
| Location | 9855 Hospital Dr Ste 275, Maple Grove, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760771398 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 59753 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Park Nicollet Methodist Hospital | Saint louis park, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Park Nicollet Clinic | 7911819438 | 1529 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard of care for first- and second-line treatment of platinum-sensitive ovarian cancer, pegylated liposomal doxorubicin (PLD)/carboplatin will replace paclitaxel/carboplatin as the standard second-line treatment for patients who remain platinum sensitive.
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful initial dosing of healthy volunteers in a first-in-human clinical trial with Spiegelmer® NOX-A12. NOX-A12 is NOXXON's second drug candidate entering the clinical stage of development within only five months.
The largest study examining the relationship between the traditional soy-rich Japanese diet and development of prostate cancer in Japanese men has come to a seemingly contradictory conclusion: intake of isoflavone chemicals, derived largely from soy foods, decreased the risk of localized prostate cancer but increased the risk of advanced prostate cancer.
"Is there a doctor on board?" Hearing this call go out at 36,000 feet can be anxiety-provoking for any physician and may trigger a dilemma of whether to respond, or wait to see if anyone else will offer their expertise.
› Verified 2 days ago
| Entity Name | Park Nicollet Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780621904 PECOS PAC ID: 7911819438 Enrollment ID: O20031104000046 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard of care for first- and second-line treatment of platinum-sensitive ovarian cancer, pegylated liposomal doxorubicin (PLD)/carboplatin will replace paclitaxel/carboplatin as the standard second-line treatment for patients who remain platinum sensitive.
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful initial dosing of healthy volunteers in a first-in-human clinical trial with Spiegelmer® NOX-A12. NOX-A12 is NOXXON's second drug candidate entering the clinical stage of development within only five months.
The largest study examining the relationship between the traditional soy-rich Japanese diet and development of prostate cancer in Japanese men has come to a seemingly contradictory conclusion: intake of isoflavone chemicals, derived largely from soy foods, decreased the risk of localized prostate cancer but increased the risk of advanced prostate cancer.
"Is there a doctor on board?" Hearing this call go out at 36,000 feet can be anxiety-provoking for any physician and may trigger a dilemma of whether to respond, or wait to see if anyone else will offer their expertise.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maureen Ann Mcdonald, MD 9855 Hospital Dr Ste 275, Maple Grove, MN 55369-4778 Ph: (952) 993-3282 | Maureen Ann Mcdonald, MD 9855 Hospital Dr Ste 275, Maple Grove, MN 55369-4778 Ph: (952) 993-3282 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard of care for first- and second-line treatment of platinum-sensitive ovarian cancer, pegylated liposomal doxorubicin (PLD)/carboplatin will replace paclitaxel/carboplatin as the standard second-line treatment for patients who remain platinum sensitive.
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful initial dosing of healthy volunteers in a first-in-human clinical trial with Spiegelmer® NOX-A12. NOX-A12 is NOXXON's second drug candidate entering the clinical stage of development within only five months.
The largest study examining the relationship between the traditional soy-rich Japanese diet and development of prostate cancer in Japanese men has come to a seemingly contradictory conclusion: intake of isoflavone chemicals, derived largely from soy foods, decreased the risk of localized prostate cancer but increased the risk of advanced prostate cancer.
"Is there a doctor on board?" Hearing this call go out at 36,000 feet can be anxiety-provoking for any physician and may trigger a dilemma of whether to respond, or wait to see if anyone else will offer their expertise.
› Verified 2 days ago
Kathryn G Flory, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9825 Hospital Dr Ste 300, Maple Grove, MN 55369 Phone: 763-587-7900 Fax: 763-494-7501 | |
Christine Suzanne Goudge Walker, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 15800 95th Ave N, Park Nicollet - Dept Of Ob/gyn, Maple Grove, MN 55369 Phone: 952-993-3282 | |
Katie Corcoran, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9825 Hospital Dr Ste 300, Maple Grove, MN 55369 Phone: 763-587-7900 Fax: 763-494-7501 | |
Dr. Sarah A Wernimont, M.D., PH.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 14500 99th Ave N, Maple Grove, MN 55369 Phone: 763-898-1000 | |
Dr. Brigette Beth Ritter Miest, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 15800 95th Ave N, Park Nicollet Maple Grove, Maple Grove, MN 55369 Phone: 952-993-3282 Fax: 952-993-1425 | |
Kristin M Lyerly, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 9855 Hospital Dr, Maple Grove, MN 55369 Phone: 952-993-3282 | |
Leslee J Jaeger, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9875 Hospital Dr, Maple Grove, MN 55369 Phone: 763-581-1100 |